Filing Details
- Accession Number:
- 0001035267-21-000135
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-03 19:39:07
- Reporting Period:
- 2021-08-03
- Accepted Time:
- 2021-08-03 19:39:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1035267 | Intuitive Surgical Inc | ISRG | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 770416458 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1416180 | R Keith Leonard | 1020 Kifer Road Sunnyvale CA 94086 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-03 | 996 | $462.71 | 1,845 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-08-03 | 996 | $1,000.00 | 849 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-03 | 996 | $0.00 | 996 | $462.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2028-04-19 | No | 4 | M | Direct |
Footnotes
- These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 2, 2021.
- Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.